• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对肝移植受者长期预后的影响——美国国立糖尿病、消化和肾脏疾病研究所肝移植数据库的结果

The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database.

作者信息

Leonard J, Heimbach J K, Malinchoc M, Watt K, Charlton M

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

出版信息

Am J Transplant. 2008 Mar;8(3):667-72. doi: 10.1111/j.1600-6143.2007.02100.x.

DOI:10.1111/j.1600-6143.2007.02100.x
PMID:18294163
Abstract

The impact of obesity on outcomes following liver transplantation has been difficult to determine, in part due to the confounding effects of ascites on BMI. We evaluated the impact of pretransplant recipient obesity on outcomes following liver transplantation using the NIDDK Liver Transplantation Database. Pretransplant BMI, corrected for ascites, was categorized as underweight (BMI <18 kg/m(2)), normal weight (BMI 18-25 kg/m(2)), overweight (BMI 25.1-30 kg/m(2)), Class I obese (BMI 30.1-35 kg/m(2)), Class II obese (BMI 35.1-40 kg/m(2)) and Class III obese (BMI >40 kg/m(2)). Primary outcomes were patient and graft survival. Secondary outcomes included days in hospital and days in ICU. Data from 704 adult liver transplant recipients from the NIDDK LTD and a further 609 patients from the Mayo Clinic were analyzed. Early and late patient and graft survival was similar across all BMI categories. Correcting for ascites volume resulted in 11-20% of patients moving into a lower BMI classification. The relative risk for mortality increased by 7% for each liter of ascites removed. We conclude that corrected BMI is not independently predictive of patient or graft survival. Obesity, within the ranges observed in this study, should not be considered to be a contraindication to liver transplantation in the absence of other relative contraindications.

摘要

肥胖对肝移植术后预后的影响一直难以确定,部分原因是腹水对体重指数(BMI)有混杂作用。我们使用美国国立糖尿病、消化和肾脏疾病研究所(NIDDK)肝移植数据库评估了肝移植受者术前肥胖对术后预后的影响。校正腹水后的术前BMI分为体重过轻(BMI<18kg/m²)、正常体重(BMI 18 - 25kg/m²)、超重(BMI 25.1 - 30kg/m²)、I类肥胖(BMI 30.1 - 35kg/m²)、II类肥胖(BMI 35.1 - 40kg/m²)和III类肥胖(BMI>40kg/m²)。主要结局是患者和移植物存活。次要结局包括住院天数和重症监护病房(ICU)住院天数。对来自NIDDK肝移植数据库的704例成年肝移植受者以及梅奥诊所的另外609例患者的数据进行了分析。所有BMI类别中患者和移植物的早期和晚期存活情况相似。校正腹水量后,11% - 20%的患者BMI分类降低。每排出1升腹水,死亡相对风险增加7%。我们得出结论,校正后的BMI不能独立预测患者或移植物存活。在本研究观察到的范围内,肥胖在没有其他相对禁忌证的情况下不应被视为肝移植的禁忌证。

相似文献

1
The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database.肥胖对肝移植受者长期预后的影响——美国国立糖尿病、消化和肾脏疾病研究所肝移植数据库的结果
Am J Transplant. 2008 Mar;8(3):667-72. doi: 10.1111/j.1600-6143.2007.02100.x.
2
Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.低体重指数而非高体重指数会增加肝移植后死亡和移植物丢失的风险:风险受终末期肝病模型调节。
Liver Transpl. 2015 Oct;21(10):1286-94. doi: 10.1002/lt.24188.
3
Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom.超重和肥胖的肝移植受者发病率增加:英国 1325 例患者的单中心经验。
Liver Transpl. 2013 May;19(5):551-62. doi: 10.1002/lt.23618. Epub 2013 Mar 17.
4
The Effect of Recipient Body Mass Index and Its Extremes on Survival and Graft Vascular and Biliary Complications After Liver Transplantation: A Single Center Retrospective Study.受体体重指数及其极端值对肝移植术后生存、移植血管及胆道并发症的影响:一项单中心回顾性研究
Ann Transplant. 2017 Oct 13;22:611-621. doi: 10.12659/aot.903475.
5
Is Obesity Associated With Better Liver Transplant Outcomes? A Retrospective Study of Hospital Length of Stay and Mortality Following Liver Transplantation.肥胖与肝移植结局改善有关吗?肝移植后住院时间和死亡率的回顾性研究。
Anesth Analg. 2022 Jul 1;135(1):118-127. doi: 10.1213/ANE.0000000000005921. Epub 2022 Jan 21.
6
Recipient Obesity and Kidney Transplant Outcomes: A Mate-Kidney Analysis.受者肥胖与肾移植结局:配对肾脏分析
Am J Kidney Dis. 2021 Oct;78(4):501-510.e1. doi: 10.1053/j.ajkd.2021.02.332. Epub 2021 Apr 16.
7
Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.大脂变同种异体移植物和肥胖受者对肝移植存活的负面影响几乎相等。
Transplantation. 2020 Jun;104(6):1193-1200. doi: 10.1097/TP.0000000000002990.
8
UK renal transplant outcomes in low and high BMI recipients: the need for a national policy.英国低 BMI 和高 BMI 受者的肾脏移植结局:国家政策的必要性。
J Nephrol. 2020 Apr;33(2):371-381. doi: 10.1007/s40620-019-00654-7. Epub 2019 Oct 3.
9
Post-transplant obesity impacts long-term survival after liver transplantation.肝移植后肥胖会影响长期生存。
Metabolism. 2020 May;106:154204. doi: 10.1016/j.metabol.2020.154204. Epub 2020 Mar 13.
10
The impact of obesity on patient survival in liver transplant recipients: a meta-analysis.肥胖对肝移植受者患者生存的影响:一项荟萃分析。
Liver Int. 2015 Jan;35(1):164-70. doi: 10.1111/liv.12431. Epub 2014 Jan 7.

引用本文的文献

1
Obesity-associated Inflammation and Alloimmunity.肥胖相关炎症与同种免疫
Transplantation. 2025 Apr 1;109(4):588-596. doi: 10.1097/TP.0000000000005183. Epub 2024 Aug 28.
2
Deep learning assisted biomarker development in patients with chronic hepatitis B: Editorial on "Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection".深度学习辅助慢性乙型肝炎患者生物标志物的开发:关于“使用深度学习算法的计算机断层扫描分析在慢性乙型肝炎病毒感染患者中的预后作用”的社论
Clin Mol Hepatol. 2024 Oct;30(4):669-672. doi: 10.3350/cmh.2024.0563. Epub 2024 Jul 23.
3
Severe obesity is associated with worse outcomes than lean metabolic dysfunction-associated steatotic liver disease.
严重肥胖与代谢相关脂肪性肝病(lean metabolic dysfunction-associated steatotic liver disease)患者的预后不良有关。
Hepatol Commun. 2024 Jun 27;8(7). doi: 10.1097/HC9.0000000000000471. eCollection 2024 Jul 1.
4
Which patient should be prioritized for liver transplant: NAFLD?对于肝移植而言,哪种患者应被优先考虑:非酒精性脂肪性肝病(NAFLD)患者吗?
Clin Liver Dis (Hoboken). 2024 Jun 7;23(1):e0163. doi: 10.1097/CLD.0000000000000163. eCollection 2024 Jan-Jun.
5
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review.基于病理生理学的营养干预在伴有肌肉减少症的肝硬化患者中的应用:最新的叙述性综述。
Nutrients. 2024 Jan 31;16(3):427. doi: 10.3390/nu16030427.
6
Association of body mass index with post-liver transplant outcomes.体重指数与肝移植后结局的关系。
Clin Transplant. 2024 Jan;38(1):e15205. doi: 10.1111/ctr.15205. Epub 2023 Dec 1.
7
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients.从列表到恢复:肝移植患者营养状况评估和管理综述。
Nutrients. 2023 Jun 16;15(12):2778. doi: 10.3390/nu15122778.
8
The causes of death in patients with nonalcoholic steatohepatitis following liver transplantation stratified using pre-liver transplant BMI.根据肝移植前 BMI 分层的非酒精性脂肪性肝炎患者肝移植后的死亡原因。
Hepatol Int. 2023 Dec;17(6):1393-1415. doi: 10.1007/s12072-023-10529-6. Epub 2023 May 9.
9
Management and Risks Before, During, and After Liver Transplant in Individuals With Obesity.肥胖个体肝移植术前、术中和术后的管理与风险
Gastroenterol Hepatol (N Y). 2023 Jan;19(1):20-29.
10
Divergent trajectories of lean obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study.从列入名单到移植后,瘦型肥胖非酒精性脂肪性肝炎患者的不同轨迹:一项回顾性队列研究。
World J Gastroenterol. 2022 Jul 14;28(26):3218-3231. doi: 10.3748/wjg.v28.i26.3218.